loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Jtk 303

    Client Email Product
    Menu

    Jtk 303

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 203093 / DOSAGE - TABLET;ORAL - 150MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ELVITEGRAVIR(UNII: 4GDQ854U53)
    (ELVITEGRAVIR - UNII:4GDQ854U53)     		ELVITEGRAVIR150mg | 85mg

    Inactive Ingredients

    Ingredient Name
    Gilead Sciences, Inc.
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
    CROSCARMELLOSE SODIUM(M28OL1HH48)
    FD&C BLUE NO. 2(L06K8R7DQK)
    FERRIC OXIDE YELLOW(EX438O2MRT)
    HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)
    MAGNESIUM STEARATE(70097M6I30)
    POLYETHYLENE GLYCOL 3350(G2M7P15E5P)
    POLYVINYL ALCOHOL(532B59J990)
    SODIUM LAURYL SULFATE(368GB5141J)
    TALC(7SEV7J4R1U)
    TITANIUM DIOXIDE(15FIX9V2JP)
    WATER(059QF0KO0R)